Zavante Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 4

Forward Citations = 1

Loading Chart...

2 inventors (with patents filed for the assignee):

Evelyn Ellis-Grosse (4 out of 4 patents)

Paul G Ambrose (2 out of 7 patents)

4 patents: Sort by Forward Citations

1. 11541064 - Methods of identifying dosing regimens (2023-01-03),

2. 11129840 - Methods for identifying novel dosing regimens (2021-09-28),

3. 10086006 - Method for improving drug treatments in mammals (2018-10-02),

4. 9345717 - Method for improving drug treatments in mammals (2016-05-24),

Company Overview

Zavante Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies to address the increasing threat of multi-drug resistant bacterial infections. Their lead product is a novel antibiotic treatment designed to combat serious infections in hospital settings. With a dedicated team of scientists and researchers, Zavante is committed to advancing the field of infectious disease treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#1,008 in San Diego, CA

#14,063 in California

#60,704 in US

San Diego, CA, United States of America